International Stem Cell Corporation (ISCO) Leads while Regenerative Medicine Becomes a Global Interest
A publicly-traded biotech company, International Stem Cell Corporation (OTCQB: ISCO) focuses its efforts toward developing innovative solutions that advance the field of regenerative medicine. This field strives to create functional tissue to repair and replace tissue or organs that have lost their function due to damage, disease, age, and congenital defects. ISCO has contributed to regenerative science by developing its own novel stem cell technology called parthenogenesis, which uses unfertilized eggs and addresses immune-rejection among humans. Stem cells have the potential to divide and differentiate themselves into any cell type. This means that these cells can treat degenerative diseases of…